Jean-Pierre Crinelli
Founder bei NOVACYT
Vermögen: 18 974 $ am 31.03.2024
Profil
Jean-Pierre Crinelli is the founder of Novacyt SAS, where he holds the title of Independent Non-Executive Director starting in 2006.
He currently holds positions as a Non-Executive Director at Novacyt UK Holdings Ltd., Manager at SCI Padapi, and Member-Management Board at Alain Fresard Technologies-Micromecanique.
He formerly held the position of Chairman at CUP 92 SAS.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NOVACYT SAS
0,05% | 31.12.2022 | 33 981 ( 0,05% ) | 18 974 $ | 31.03.2024 |
Aktive Positionen von Jean-Pierre Crinelli
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVACYT | Founder | 03.07.2006 |
| SCI Padapi | Corporate Officer/Principal | - |
| Alain Fresard Technologies-Micromecanique | Corporate Officer/Principal | - |
Novacyt UK Holdings Ltd.
 Novacyt UK Holdings Ltd. BiotechnologyHealth Technology Part of Novacyt SAS, Novacyt UK Holdings Ltd. is a diagnostics company that develops tests that detect infections. The private company is based in Eastleigh, UK. The British company was founded in 2019. The CEO is James Martin Mccarthy. | Director/Board Member | - |
Ehemalige bekannte Positionen von Jean-Pierre Crinelli
| Unternehmen | Position | Ende |
|---|---|---|
CUP 92 SAS
 CUP 92 SAS Medical SpecialtiesHealth Technology CUP 92 SAS operates as a holding company with interest in the provision of solutions in cytology and molecular biology fields. The company was founded on March 11, 2010 and is headquartered in Compiegne, France. | Chairman | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVACYT | Health Technology |
| Private Unternehmen | 4 |
|---|---|
CUP 92 SAS
CUP 92 SAS Medical SpecialtiesHealth Technology CUP 92 SAS operates as a holding company with interest in the provision of solutions in cytology and molecular biology fields. The company was founded on March 11, 2010 and is headquartered in Compiegne, France. | Health Technology |
| SCI Padapi | |
| Alain Fresard Technologies-Micromecanique | |
Novacyt UK Holdings Ltd.
Novacyt UK Holdings Ltd. BiotechnologyHealth Technology Part of Novacyt SAS, Novacyt UK Holdings Ltd. is a diagnostics company that develops tests that detect infections. The private company is based in Eastleigh, UK. The British company was founded in 2019. The CEO is James Martin Mccarthy. | Health Technology |
